Blastomycosis Treatment Market is segmented By Treatment Type (Itraconazole, Amphotericin B), By Geo...
Market Size in USD Mn
CAGR7.1%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 7.1% |
Market Concentration | High |
Major Players | Janssen, Scynexis Inc, Novartis AG, Marck & Co., Inc., Sun Pharmaceutical Industries Ltd and Among Others |
The blastomycosis treatment market is estimated to be valued at USD 216.3 Mn in 2025 and is expected to reach USD 349.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.1% from 2025 to 2032.
There is an increasing prevalence of blastomycosis infections globally due to growing environmental pollution and contaminated water bodies. Additionally, development of newer drug molecules and treatment options by major players are expanding access to therapy.